Endoscopic sleeve gastroplasty (ESG) is emerging as a primary alternative to both traditional bariatric surgery and daily weight-loss medications. By using a flexible endoscope to place internal sutures, physicians can reduce stomach volume by up to 80% without surgical incisions. Recent patient outcomes, such as those of Molly and Diane Madore who lost a combined 163 pounds, highlight the procedure’s potential for long-term weight management.
How Does Endoscopic Sleeve Gastroplasty Work?
ESG is a minimally invasive procedure performed during an endoscopy. According to the Healthline report, a physician uses a flexible scope to place sutures within the stomach, effectively shrinking its capacity. This reduction limits the amount of food a patient can consume and promotes early satiety. Unlike traditional bariatric surgery, this approach requires no external incisions or permanent removal of stomach tissue. Dr. Rabia De Latour, an associate professor at NYU Grossman School of Medicine, notes that by reducing stomach volume, the procedure creates a physical restriction that helps patients feel full with smaller portions.
The most common side effects of ESG are gastrointestinal symptoms, such as nausea or stomach spasms. These typically resolve within 30 to 60 days following the procedure.
Comparing ESG to GLP-1 Medications
While GLP-1 injections have gained popularity for weight loss, experts point to distinct differences between medication and procedure-based interventions. Dr. De Latour explains that the effects of weight-loss medications often wane after a patient stops taking them, which can lead to recurrent weight gain. In contrast, ESG provides a physical change to the stomach structure. For patients like Molly Madore, who experienced GI side effects while on GLP-1 injections, the shift to a non-medication-based strategy offered a way to manage weight without daily pharmaceutical dependence.
Who Is a Candidate for ESG?
Clinical guidelines generally identify candidates for ESG as individuals with a body mass index (BMI) between 30 and 50. According to the experience of the Madore family, insurance coverage can be a hurdle, particularly for patients with fewer comorbidities. Molly Madore’s procedure was the first of its kind at her facility, highlighting that access to this technology is still expanding across regional health systems. Clinicians recommend that patients consult with their medical team to weigh the benefits of procedure-based restriction against their specific health history and recovery goals.
Pro Tips for Post-Procedure Success
- View it as a tool: Patients report that ESG is most effective when paired with a commitment to long-term lifestyle changes rather than viewed as a “quick fix.”
- Accountability matters: Engaging with a support system, or even undergoing the process with a family member, can help maintain motivation during the recovery phase.
- Monitor recovery: Many patients return to work within days, but initial recovery may require temporary medication to manage muscle spasms.
Frequently Asked Questions
Is ESG considered surgery?
No. ESG is a non-surgical, minimally invasive endoscopic procedure. It does not involve incisions, cutting, or the removal of any stomach tissue.
How much weight can you lose with ESG?
Results vary by individual. In the case of the Madore family, the two patients lost 86 pounds and 77 pounds, respectively, following their procedures.
How long does the recovery take?
Many patients return to work within a few days. Common side effects, such as nausea or cramping, typically resolve within one to two months.
Are you exploring weight management options? Join the conversation in the comments below or subscribe to our newsletter for the latest updates on non-invasive medical procedures.